Normalization of Enzyme Expression and Activity Regulating Vitamin A Metabolism Increases RAR-Beta Expression and Reduces Cellular Migration and Proliferation in Diseases Caused by Tuberous Sclerosis Gene Mutations.
Normalization of Enzyme Expression and Activity Regulating Vitamin A Metabolism Increases RAR-Beta Expression and Reduces Cellular Migration and Proliferation in Diseases Caused by Tuberous Sclerosis Gene Mutations.
复制标题
调节维生素A代谢的酶的表达和活性的正常化增加了RAR-Beta的表达,并减少了由结节性硬化症基因突变引起的疾病中的细胞迁移和增殖。
DOI:
10.3389/fonc.2021.644592
复制
发表时间:
2021
影响因子:
4.7
通讯作者:
Pongracz JE
中科院分区:
文献类型:
--
作者:
Abdelwahab EMM;Bovari-Biri J;Smuk G;Harko T;Fillinger J;Moldvay J;Krymskaya VP;Pongracz JE
Mutation in a tuberous sclerosis gene (TSC1 or 2) leads to continuous activation of the mammalian target of rapamycin (mTOR). mTOR activation alters cellular including vitamin A metabolism and retinoic acid receptor beta (RARβ) expression. The goal of the present study was to investigate the molecular connection between vitamin A metabolism and TSC mutation. We also aimed to investigate the effect of the FDA approved drug rapamycin and the vitamin A metabolite retinoic acid (RA) in cell lines with TSC mutation. Expression and activity of vitamin A associated metabolic enzymes and RARβ were assessed in human kidney angiomyolipoma derived cell lines, primary lymphangioleiomyomatosis (LAM) tissue derived LAM cell lines. RARβ protein levels were also tested in primary LAM lung tissue sections. TaqMan arrays, enzyme activities, qRT-PCRs, immunohistochemistry, immunofluorescent staining, and western blotting were performed and analysed. The functional effects of retinoic acid (RA) and rapamycin were tested in a scratch and a BrDU assay to assess cell migration and proliferation. Metabolic enzyme arrays revealed a general deregulation of many enzymes involved in vitamin A metabolism including aldehyde dehydrogenases (ALDHs), alcohol dehydrogenases (ADHs) and Cytochrome P450 2E1 (CYP2E1). Furthermore, RARβ downregulation was a characteristic feature of all TSC-deficient cell lines and primary tissues. Combination of the two FDA approved drugs -RA for acute myeloid leukaemia and rapamycin for TSC mutation- normalised ALDH and ADH expression and activity, restored RARβ expression and reduced cellular proliferation and migration. Deregulation of vitamin A metabolizing enzymes is a feature of TSC mutation. RA can normalize RARβ levels and limit cell migration but does not have a significant effect on proliferation. Based on our data, translational studies could confirm whether combination of RA with reduced dosage of rapamycin would have more beneficial effects to higher dosage of rapamycin monotherapy meanwhile reducing adverse effects of rapamycin for patients with TSC mutation.
登录
查看更多内容
影响因子:
5.3
作者:
Flamini MI;Gauna GV;Sottile ML;Nadin BS;Sanchez AM;Vargas-Roig LM
通讯作者:
Vargas-Roig LM
影响因子:
5.9
作者:
Chelstowska S;Widjaja-Adhi MA;Silvaroli JA;Golczak M
通讯作者:
Golczak M
影响因子:
3.4
作者:
Cheung, Yuen-Ting;Lau, Way Kwok-Wai;Chang, Raymond Chuen-Chung
通讯作者:
Chang, Raymond Chuen-Chung
影响因子:
8
作者:
Li, Yang;Wongsiriroj, Nuttaporn;Blaner, William S
通讯作者:
Blaner, William S
DOI:
10.1165/rcmb.2012-0476oc
发表时间:
2013-07-01
影响因子:
6.4
作者:
Li, Chenggang;Zhou, Xiaobo;Yu, Jane J.
通讯作者:
Yu, Jane J.